JW
Justin Walsh Jones Trading Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Lantheus
LNTH
$3.65B
| $55.07 | $109 |
98%
upside
| Buy |
23 Jun ‘25
2 months ago |
|
2
VolitionRX
VNRX
$68.5M
| $0.6370 | $3 |
371%
upside
| Buy |
10 Jun ‘25
3 months ago |
|
|
BLRX
3
BioLineRX
BLRX
$15.6M
| $3.65 | $12 |
229%
upside
| Buy |
30 May ‘25
3 months ago |
|
4
Clene
CLNN
$66.2M
| $6.60 | $30 |
355%
upside
| Buy |
23 Apr ‘25
4 months ago |
|
5
Serina Therapeutics
SER
$54.9M
| $5.36 | $11 |
105%
upside
| Buy |
11 Mar ‘25
6 months ago |
|
6
Alto Neuroscience
ANRO
$105M
| $3.77 | $18 |
377%
upside
| Buy |
16 Dec ‘24
8 months ago |
|
|
RAPP
7
Rapport Therapeutics
RAPP
$1.02B
| $28.03 | $42 |
50%
upside
| Buy |
18 Oct ‘24
10 months ago |
|
|
8
Lantheus
LNTH
$3.65B
| $55.07 | $137 |
149%
upside
| Buy |
19 Jul ‘24
1 year ago |
|
9
Perspective Therapeutics
CATX
$255M
| $3.37 | $22 |
553%
upside
| Buy |
16 May ‘24
1 year ago |
|
10
TriSalus Life Sciences
TLSI
$250M
| $4.90 | $16 |
227%
upside
| Buy |
10 May ‘24
1 year ago |
|
11
Achieve Life Sciences
ACHV
$159M
| $3.12 | $20 |
541%
upside
| Buy |
17 Apr ‘24
1 year ago |
|
|
12
Perspective Therapeutics
CATX
$255M
| $3.37 | $14 |
315%
upside
| Buy |
15 Nov ‘23
1 year ago |
|
13
Cytosorbents Corp
CTSO
$62.6M
| $0.9980 | $4 |
301%
upside
| Buy |
7 Sep ‘23
2 years ago |
|
14
Prime Medicine
PRME
$734M
| $4.12 | $20 |
385%
upside
| Buy |
6 Sep ‘23
2 years ago |
|
|
THTX
15
Theratechnologies
THTX
$150M
| $3.27 | $12 |
267%
upside
| Buy |
17 Jul ‘23
2 years ago |
|
16
Vor Biopharma
VOR
$255M
| $2.01 | $18 |
796%
upside
| Buy |
16 May ‘23
2 years ago |
|
17
Mainz Biomed
MYNZ
$7.6M
| $1.66 | $440 |
26,406%
upside
| Buy |
10 Feb ‘23
2 years ago |
|
18
Plus Therapeutics
PSTV
$49M
| $0.4933 | $75 |
15,104%
upside
| Buy |
7 Oct ‘22
2 years ago |
|
|
19
Lantheus
LNTH
$3.65B
| $55.07 | $104 |
89%
upside
| Buy |
7 Oct ‘22
2 years ago |
|
20
Harrow
HROW
$1.45B
| $39.30 | $20 |
49%
downside
| Buy |
20 May ‘22
3 years ago |
|
21
Curis
CRIS
$21.4M
| $1.81 | $200 |
10,950%
upside
| Buy |
5 Apr ‘22
3 years ago |
|
22
Compass Therapeutics
CMPX
$597M
| $3.48 | $10 |
187%
upside
| Buy |
19 Jan ‘22
3 years ago |
|
|
ATON
23
AlphaTON Capital Corp. Common Stock
ATON
$13.7M
| $6 | $800 |
13,233%
upside
| Buy |
2 Sep ‘21
4 years ago |
|
|
24
Vor Biopharma
VOR
$255M
| $2.01 | $60 |
2,885%
upside
| Buy |
25 Mar ‘21
4 years ago |
|